Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Fulgent Genetics, Inc.’s reported figures.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
FAQ
- What is Fulgent Genetics, Inc.'s EBIT?
- Fulgent Genetics, Inc. (FLGT) reported EBIT of -$34.62M in Q1 2026.
- How has Fulgent Genetics, Inc.'s EBIT changed year-over-year?
- Fulgent Genetics, Inc.'s EBIT decreased by 74.9% year-over-year, from -$19.8M to -$34.62M.
- What is the long-term trend for Fulgent Genetics, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s EBIT has grown at a -39.4% compound annual growth rate (CAGR), from $675.95M to -$91.1M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Fulgent Genetics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude